Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from AstraZeneca

GSK reports promising early results in ovarian and womb cancer drug trial

Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug

The Guardian - UK

FTSE 100 ends down as oil rises while Iran war remains in deadlock

The FTSE 100 closed down just 4.82 points at 9,967.35.

Evening Standard

‘We were told it was safe’: Inside the legal battle over Covid vaccine deaths in India

IN FOCUS: In a landmark ruling, India’s top court orders a compensation framework for victims of rare but potentially deadly side effects following Covid vaccination. It’s a victory for families – but questions about transparency, consent and trust remain unresolved. Namita Singh reports

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Chinese-owned Syngenta to build new £100m bioscience hub in UK

Agrichemical group will open a research centre in Berkshire, in a move hailed by UK government as ‘clear’ vote of confidence

The Guardian - UK

Sir Ronnie Hampel obituary

Chief executive and chairman of ICI in the 1990s who oversaw the creation of the pharmaceutical company Zeneca

The Guardian - UK

Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn

UK’s GSK is leading the way in research but AstraZeneca is not involved in the area, report finds

The Guardian - UK

COVID vaccination: we now may know why some people developed blood clots

COVID vaccines saved millions of lives, but months into the rollout, a small number of people began developing dangerous blood clots in unusual parts of the body. These only happened after vaccines that used a modified adenovirus to deliver its payload – such as the AstraZeneca vaccine. Why these blood…

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Emma Walmsley’s pay rose almost 50% to £15.6m in final year as GSK boss

Bulk of 2025 renumeration came from share bonuses as drug company’s now former CEO benefitted from stock rise

The Guardian - UK

Hannah Spencer: the Green MP speaking to everyday people’s frustrations

Winner of Gorton and Denton byelection was driven into politics by growing gap between super-rich and the ‘rest of us’

The Guardian - UK

HSBC reclaims top spot as FTSE 100 hits new high

The FTSE 100 index ended up 1.2% at 10,806.41, a record close.

Evening Standard

AstraZeneca boss Pascal Soriot nets £17.7m in pay and bonuses for 2025

The drug maker’s annual report showed his total pay lifted 6.4% last year after he was awarded nearly £16 million in bonuses and share awards.

Evening Standard

AstraZeneca boss Pascal Soriot’s pay rises to £17.7m

Increase of 6.4% comes as drugmaker reports strong profit growth, despite cancelling UK investment projects

The Guardian - UK

Cheaper diabetes drug halted by AstraZeneca court win

Consumers will have to wait longer for a more affordable diabetes and heart failure drug after pharmaceutical giant AstraZeneca had a win in court.

AAP

Weight-loss race: how switch from injections to pills is expanding big pharma’s hopes

Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH

With after-tax profits surging by close to 50% year-over-year, AstraZeneca emerges as a potential winner among healthcare names reporting earnings this month.

The Guardian - UK

AstraZeneca CEO hails NHS drug price deal but keeps pause on £200m UK investment

Pascal Soriot suggests UK-US agreement will not be enough to revive plan to expand Cambridge site

Evening Standard

AstraZeneca profits jump by 40% amid strong demand for cancer drugs

Shares edged 1% higher in morning trading on Tuesday, with the stock having risen 28% in the past six months.

The Guardian - UK

GSK, take two: the bullish tone at the top is finally more convincing

New boss Luke Miels knows perils of overpromising but there is growing sense pharma firm is closer to filling potential

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

FTSE 100 sets new record despite metals meltdown

Gold was quoted lower at 4,696.11 dollars an ounce on Monday, down sharply against 5,003.82 dollars at the same time on Friday.

Evening Standard

AstraZeneca shares launch on New York Stock Exchange

The UK based-pharmaceutical giant is transitioning to the market by delisting American Depositary Shares from the Nasdaq index.

Evening Standard

AstraZeneca secures tie-up with Chinese firm for weight loss drugs

The deal includes giving AstraZeneca access to the exclusive global rights, outside China, to CSPC’s once-a-month weight management jabs.

Evening Standard

FTSE 100 Live 30 January: Gold and silver prices slump, AstraZeneca strikes China deal

The price of gold today fell back as traders focused on President Trump’s nomination as next Federal Reserve chair.

The Guardian - UK

AstraZeneca to invest £11bn in China after rowing back on UK expansion

Keir Starmer says the move, announced during his trip to Beijing, will help support thousands of British jobs

Evening Standard

Who is on Keir Starmer's China trip, and why are they there?

A delegation of ministers, business leaders and cultural figures are part of the trip, as the Prime Minister seeks to improve relations

Euronews

From wildfires to inhalers: The hidden environmental cost of respiratory care and how tech may help

As climate change worsens respiratory diseases, doctors and drugmakers are exploring earlier diagnosis and low-carbon inhalers to cut emissions from care and protect patients.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.